Viyash Scientific Ltd is Rated Hold

Current Rating and Its Significance

MarketsMOJO’s 'Hold' rating for Viyash Scientific Ltd indicates a balanced stance on the stock, suggesting that investors should maintain their current positions rather than aggressively buying or selling. This rating reflects a nuanced view of the company’s prospects, weighing both strengths and challenges across multiple parameters. The Mojo Score, a composite measure of various financial and market factors, currently stands at 56.0, placing the stock in the 'Hold' category. This score improved from 46.0, which corresponded to a 'Sell' rating prior to 08 Apr 2026.

Quality Assessment

As of 01 May 2026, Viyash Scientific’s quality grade is assessed as below average. This is primarily due to its weak long-term fundamental strength. The company’s Return on Capital Employed (ROCE) averages 7.40%, which is modest and indicates limited efficiency in generating profits from its capital base over the long term. Additionally, net sales have grown at a compound annual growth rate (CAGR) of 14.17% over the past five years, while operating profit has increased at 12.25% annually. These growth rates, though positive, are not robust enough to elevate the quality grade significantly. Furthermore, the company’s debt servicing capacity is constrained, with a Debt to EBITDA ratio of 1.32 times, signalling moderate leverage risk.

Valuation Considerations

Viyash Scientific is currently rated as expensive in terms of valuation. The stock trades at an Enterprise Value to Capital Employed (EV/CE) multiple of 7.6, which is higher than the average for its peer group. Despite this, the stock price has recently been trading at a discount relative to historical valuations of comparable companies in the Pharmaceuticals & Biotechnology sector. The Price/Earnings to Growth (PEG) ratio stands at 1.7, reflecting a valuation that factors in the company’s earnings growth prospects. Investors should note that while the stock’s valuation appears elevated, it is somewhat justified by the company’s recent strong profit growth.

Financial Trend and Recent Performance

The financial trend for Viyash Scientific is outstanding, a key factor supporting the 'Hold' rating. The company reported a remarkable 78.2% growth in operating profit in the December 2025 quarter, marking its eighth consecutive quarter of positive results. Profit Before Tax excluding other income (PBT LESS OI) reached ₹100.35 crores, representing a staggering 384.55% increase. The half-year ROCE peaked at 18.65%, and the operating profit to interest coverage ratio was an impressive 10.49 times, indicating strong operational efficiency and financial health in the short term. These figures demonstrate a significant turnaround in profitability and operational performance, which investors should consider alongside the longer-term fundamental challenges.

Technical Outlook

From a technical perspective, the stock exhibits a mildly bullish trend. Over the past month, Viyash Scientific’s share price has gained 11.44%, although it has experienced some volatility with a 3-month return of -0.17% and a 6-month decline of 4.31%. Year-to-date, the stock is down 1.92%, but over the last year, it has delivered a robust 41.62% return, outperforming the BSE500 index consistently over the past three years. This price action suggests that while short-term fluctuations exist, the stock maintains positive momentum and investor interest.

Shareholding and Market Capitalisation

Viyash Scientific Ltd is classified as a small-cap company within the Pharmaceuticals & Biotechnology sector. The majority shareholding is held by promoters, which often implies stable control and alignment of interests with long-term shareholders. This ownership structure can provide some reassurance to investors regarding governance and strategic direction.

Summary for Investors

In summary, the 'Hold' rating for Viyash Scientific Ltd reflects a balanced view that acknowledges the company’s recent outstanding financial performance and positive technical signals, while also recognising its below-average quality metrics and relatively expensive valuation. Investors should consider maintaining their current holdings, monitoring the company’s ability to sustain profit growth and improve its fundamental quality over time. The stock’s strong recent returns and operational improvements offer potential upside, but caution is warranted given the underlying leverage and valuation concerns.

Performance Metrics at a Glance

As of 01 May 2026, the stock’s recent returns highlight its mixed but generally positive momentum. The one-day change was -1.52%, and the one-week return was -3.66%, reflecting some short-term volatility. However, the one-month return of +11.44% and the one-year return of +41.62% underscore the stock’s capacity for strong gains over longer periods. The company’s consistent positive quarterly results and significant profit growth reinforce the financial trend’s strength.

Outlook and Considerations

Investors should weigh the company’s outstanding recent financial results against its longer-term fundamental challenges. The below-average quality grade and high valuation suggest that caution is prudent, especially for those seeking stable, low-risk investments. Conversely, the strong financial trend and technical momentum may appeal to investors with a higher risk tolerance looking for growth opportunities in the Pharmaceuticals & Biotechnology sector.

Conclusion

Viyash Scientific Ltd’s 'Hold' rating by MarketsMOJO, last updated on 08 Apr 2026, reflects a comprehensive evaluation of quality, valuation, financial trend, and technical factors as of 01 May 2026. This balanced recommendation advises investors to maintain their current positions while closely monitoring the company’s ongoing performance and market conditions. The stock’s recent profit surge and consistent returns offer promise, but investors should remain mindful of valuation and fundamental risks inherent in the company’s profile.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today